Ticker
ADCTCompany Name
ADC THERAPEUTICS SASector
HealthcareIndustry
BiotechnologyExchange
NYSEDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ -199.18M | $ -169.94M | 0% |
3/31/2025 | $ -238.22M | $ -149.84M | 0% |
12/31/2024 | $ -202.64M | $ -157.85M | 0% |
9/30/2024 | $ -171.95M | $ -212.82M | 0% |
6/30/2024 | $ -131.67M | $ -216.66M | 0% |
3/31/2024 | $ -194.45M | $ -227.23M | 0% |
12/31/2023 | $ -148.25M | $ -240.05M | 0% |
9/30/2023 | $ -54.18M | $ -178.51M | 0% |
6/30/2023 | $ -8.59M | $ -181.31M | 0% |
3/31/2023 | $ 37.69M | $ -198.56M | -526.91% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for ADC THERAPEUTICS SA is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 376.06M ]
(=) ROE [ 0% ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.25% |
average | 1.51% |
median | 6.45% |
std | 22.67% |